Nonetheless, for GLP-1 and other specialty meds, the push toward ePA has accelerated because every 30% reduction in approval time translates into concrete gains in patient outcomes (timely titration) and provider efficiency ( [45] ) ( [46] )
Physicians and drug manufacturers caution that GLP-1 medications should not be taken by patients with a history of medullary thyroid cancer, MEN2 (multiple endocrine neoplasia syndrome type 2) or a history of gastritis
If you are ready to understand your options, the providers at Perfect B in Doral will evaluate you, explain whether GLP-1 therapy fits, and build a supervised plan that protects your muscle and your results
That's not a willpower problem
Doi: Barone, Eugenio, Elizabeth Head, D